Data compiled by Redley Lamar · ChainSifter Intelligence
0Suppliers
6Customers
3Debt Items
14Related Chains
Source-Backed Evidence Depth
Champions Oncology, Inc. (CSBR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
3Distinct source URLs
5High confidence
0.782Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Champions Oncology, Inc. Suppliers
No suppliers on recordChampions Oncology, Inc. does not appear to disclose named supplier relationships in its verified regulatory filings, or upstream suppliers have not yet been identified. Our system processes new filings continuously.
Champions Oncology, Inc. Customers
Ticker
Name
Confidence
Evidence
ONE-CUSTOMER
ONE-CUSTOMER
92%
For the year ended April 30, 2024, one of our customers accounted for more than 10% of our total revenue, at 10%.
ant components of Lumin: the Datacenter and the Analytics. While we feel our Datacenter is unique, there are a large number of publicly available datasets that can be accessed free of charge for comp…
Reciprocal relationship from MAR graph: Reciprocal relationship from CSBR graph: ant components of Lumin: the Datacenter and the Analytics. While we feel our Datacenter is unique, there are a large n…
CORELLIA-AI-INC
CORELLIA-AI-INC
62%
24 and 2023 was approximately $12.0 million and $12.7 million, respectively. We identified the accounting for revenue and the related deferred revenue recognized over time as a critical audit matter …
INTERNATIONAL-GROUP-INC
INTERNATIONAL-GROUP-INC
62%
ant components of Lumin: the Datacenter and the Analytics. While we feel our Datacenter is unique, there are a large number of publicly available datasets that can be accessed free of charge for comp…
PRESENTATION-BACKGROUND-CHAMPIONS-ONCOLOGY-INC
PRESENTATION-BACKGROUND-CHAMPIONS-ONCOLOGY-INC
62%
24 and 2023 was approximately $12.0 million and $12.7 million, respectively. We identified the accounting for revenue and the related deferred revenue recognized over time as a critical audit matter …
Champions Oncology, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
CSBR-DEBT
Debt stack $5.0M
90%
Market cache reports total debt of $5.0M.
CSBR-DEBT-8882
Warrants outstanding: 5.76
90%
xbrl warrant detail from xbrl 2021-04-30.
CSBR-DEBT-8883
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2016-04-30.
Champions Oncology, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Champions Oncology, Inc..
Champions Oncology, Inc. Ownership
Holder
Name
Confidence
Evidence
CSBR-OWNER-BATTERY-MANAGEMENT-CORP
BATTERY MANAGEMENT CORP.
90%
13F overlay lists BATTERY MANAGEMENT CORP. as top holder; 26 tracked holders.
Champions Oncology, Inc. Extended Supply Chain Network
